WonderTx YC 申请

Summer 2026Active

San Francisco

WonderTx 在 Summer 2026 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。

YC 批次: Summer 2026
行业: HealthcareTherapeutics
地点: San Francisco
团队规模: 3
状态: Active
已发布: 2026

创始人

Abraham HeifetsFounder/CEO

WonderTx 做什么

We’re an AI-native biotech, working on replacing needles with pills. Many drugs, like insulin or Ozempic, are wonderful except you have to inject them. We discover new molecules that you can take as a pill instead. Because the pills operate on biology which has been shown to be effective in people, rather than merely in animal models of disease, we avoid what has historically been the single biggest risk in drug discovery. This should dramatically increase our probability of success. There’s $200B of treatable diseases and validated human biology without a pill because discovery programs lack a tractable chemical starting point. This is a zero-shot inference problem, because these targets have no training data, so LLMs and other historical interpolative AI approaches are insufficient. Instead, we are building our own extrapolative frontier models that reason beyond their training data. Most critically, we have repeatedly validated our platform on both our own and partner programs. On 4 biologically- and structurally-diverse targets where we had zero training data, we successfully picked binders that were validated experimentally, with confirmation ranging from primary screen hits to crystallographic structures.

WonderTx 的 YC 申请，重建版

Y Combinator 申请

WonderTx，Summer 2026 期。来自公开数据的真实申请问题解答。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

WonderTx

Describe what your company does in 50 characters or less.

AI discovers pills to replace injectable drugs

What is your company going to make? Please describe your product and what it does or will do.

We are building an AI-native biotech platform for oral drug discovery. Our tech designs new molecules that let you take, for example, insulin or Ozempic as a pill instead of a shot. Our models are trained to reason on targets that have worked in real humans, not just in animal models, removing the main risk in drug discovery. Drug discovery teams use our molecules to pursue first-in-class oral drugs for validated biology where there was no tractable starting point before.

Where do you live now, and where would the company be based after YC?

We are based in San Francisco, CA, USA, and work remotely. After YC, we will remain based in San Francisco and remote.

Explain your decision regarding location.

San Francisco has a deep biotech and AI ecosystem, which helps on both the research and fundraising side. Our work is computational and experimental, so we work distributed, but physically close to the Bay Area network.

21 更多回答在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。

查看完整申请

常见问题解答

这是 WonderTx 的真实 YC 申请吗？

不是。Y Combinator 对提交的申请保密。这是重建版：使用 WonderTx 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 WonderTx 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。

WonderTx 是哪个 YC 批次的？

WonderTx 是 Y Combinator Summer 2026 批次的成员。

谁创立了 WonderTx？

WonderTx 由 Abraham Heifets 创立。

WonderTx 做什么？

Extrapolative AI to unlock First-in-Class drugs

如何阅读完整的重建申请？

创建免费的 Round Funded 账户。YC Insights 中包含 WonderTx 的完整 26 个问题的版本，以及其他所有 YC 批次的公司信息。